Nurix Therapeutics NRIX
NASDAQ NRIX
$23.67 +0.00 (+0.02%)
At close: Sep 29, 2026 · 4:00 PM EDT

Nurix Therapeutics (NRIX) FCF Margin (2019 - 2026)

Updated

Nurix Therapeutics (NRIX) reported FCF Margin of -1089.34% for fiscal Q2 2026 (quarter ended May 31, 2026), down 939.90 percentage points from -149.44% a year earlier but up 77.63 percentage points from the prior quarter.

Analysis

Nurix Therapeutics (NRIX) FCF Margin (2019 - 2026) Analysis & Trends

Over the twelve months ended May 31, 2026, Nurix Therapeutics' FCF Margin came in at -828.28%, down 572.81 percentage points year-over-year; for FY2025 (ended Nov 30, 2025), it came in at -313.73%, up 19.66 percentage points from FY2024.

  • FCF Margin has a five-year change of -287.73 percentage points (FY2020 to FY2025).
  • By fiscal year, FCF Margin came in at -333.38% in FY2024 (-216.78 pp), -116.60% in FY2023 (+328.82 pp), -445.42% in FY2022 (-142.81 pp) and -302.61% in FY2021 (-276.61 pp).
  • Five-year quarterly FCF Margin spans a low of -1166.97% in fiscal Q1 2026 and a high of 159.01% in fiscal Q4 2023.
  • Year over year, FCF Margin has now declined in each of the last four quarters, with an average year-over-year change of -357.91 percentage points over the last eight quarters.
  • The high point for year-over-year FCF Margin in five years was fiscal Q4 2023 (a gain of 756.38 percentage points); the low point was fiscal Q2 2026 (a drop of 939.90 percentage points).
  • Per Business Quant data, the three fiscal quarters before Q2 2026 came in at -1166.97% (Q1 2026), -537.40% (Q4 2025) and -761.29% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 28.82%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 18.33%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 26.96%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 43.05%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 34.72%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 34.70%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 44.00%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 2.01%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 30.39%
10 Nurix Therapeutics 2.45 Bn 448.58 Mn - -1,089.34%
Historic Data

Historic Data

Download Data
DateValue
May 31, 2026 -1,089.34%
Feb 28, 2026 -1,166.97%
Nov 30, 2025 -537.40%
Aug 31, 2025 -761.29%
May 31, 2025 -149.44%
Feb 28, 2025 -349.93%
Nov 30, 2024 -382.84%
Aug 31, 2024 -353.70%
May 31, 2024 -344.38%
Feb 29, 2024 -270.33%
Nov 30, 2023 159.01%
Aug 31, 2023 -236.05%
May 31, 2023 -63.73%
Feb 28, 2023 -399.91%
Nov 30, 2022 -597.38%
Aug 31, 2022 -460.81%
May 31, 2022 -312.31%
Feb 28, 2022 -479.18%
Nov 30, 2021 -429.60%
Aug 31, 2021 -310.54%
API Access

Nurix Therapeutics FCF Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=fcf-margin&ticker=NRIX&period=max&api_key=YOUR_API_KEY